Emma Reeve
CIK 1680329 · Chief Financial Officer · last filed 2026-06-15
Emma Reeve is a Chief Financial Officer who has filed 56 SEC Form 4 insider transactions across 6 companies since 2016. The most recent filing, for WHWK, was dated Jun 15, 2026. Across all open-market trades the lifetime net is −$10.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $763.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$763.5K
6
56
-$10.27M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WHWK | Director | — | $4.47 | — | $0 | 2 | 2026-06-15 |
| PTCT | Director | 10,666 | $71.58 | $763.5K | -$6.12M | 18 | 2026-01-06 |
| Whitehawk Therapeutics, Inc. (AADI) Delisted | Director | — | $2.05 | — | $0 | 4 | 2024-06-14 |
| EDIT | Director | — | $2.83 | — | $0 | 4 | 2024-06-03 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Chief Financial Officer | 6,260 | $33.99 | $212.8K | -$4.16M | 16 | 2021-02-23 |
| PAREXEL INTERNATIONAL CORP (PRXL) Delisted | Corp. VP & Interim CFO | 8,468 | — | — | $0 | 1 | 2016-12-09 |
Recent Filings
56 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | WHWK | Grant (A) | — | $0 | EDGAR |
| 2026-01-06 | PTCT | Mixed | +4,000 | -$21.6K | EDGAR |
| 2026-01-05 | PTCT | Notice (144) | −734 | -$55.8K | EDGAR |
| 2025-12-05 | PTCT | Mixed | — | -$23.5K | EDGAR |
| 2025-12-03 | PTCT | Notice (144) | −733 | -$57.6K | EDGAR |
| 2025-11-25 | PTCT | Mixed | — | -$283.4K | EDGAR |
| 2025-11-21 | PTCT | Notice (144) | −10,000 | -$795.0K | EDGAR |
| 2025-11-14 | PTCT | Mixed | — | -$205.0K | EDGAR |
| 2025-11-12 | PTCT | Notice (144) | −7,333 | -$546.3K | EDGAR |
| 2025-10-31 | PTCT | Mixed | −3,666 | -$631.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.